Filing Details
- Accession Number:
- 0001127602-25-007937
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-04 16:34:58
- Reporting Period:
- 2025-02-28
- Filing Date:
- 2025-03-04
- Accepted Time:
- 2025-03-04 16:34:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2020619 | D Michael Shafer | 168 Third Avenue Waltham MA 02451 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-02-28 | 245 | $528.96 | 21,805 | No | 4 | F | Direct | |
Common Stock | Disposition | 2025-02-28 | 110 | $528.96 | 21,695 | No | 4 | F | Direct | |
Common Stock | Disposition | 2025-02-28 | 636 | $528.96 | 21,059 | No | 4 | F | Direct | |
Common Stock | Disposition | 2025-03-03 | 1,780 | $530.92 | 19,279 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Reflects a downward adjustment of 349 shares of a performance-based restricted stock unit award granted on February 23, 2022. On February 22, 2023, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 28, 2023, one-third of the shares vested on February 28, 2024, and the remaining one-third vested on February 28, 2025, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2022, through to December 31, 2024. As a result of the Company's relative TSR, the third tranche was adjusted downward by 30%. As such, the reporting person received 349 less shares than the amount initially reported.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2024